TickerFacts.

YD Bio Ltd (YDES): R&D Expense

Annual figures by period end, from SEC filings.

$1.60M
Year ended 2025-12-31
2024-12-31: $491.4K2025-12-31: $1.60M$1.60M
2024-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$1.60M+226.1%2026-04-30, From 2025-01-01
2024-12-31$491.4Kn/a2026-04-30, From 2024-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
YD Bio Ltd (YDES)2025-12-31$1.60M+226.1%
Sera Prognostics, Inc. (SERA)2025-12-31$13.17M-10.6%
Aclarion, Inc. (ACON)2025-12-31$1.03M+16.3%
BioNexus Gene Lab Corp (BGLC)2025-12-31$50.7K+6.6%
Exagen Inc. (XGN)2025-12-31$6.25M+16.4%
Personalis, Inc. (PSNL)2025-12-31$50.26M+2.8%
Biodesix Inc (BDSX)2025-12-31$12.00M+25.5%
GRAIL, Inc. (GRAL)2025-12-31$195.79M-39.3%
BillionToOne, Inc. (BLLN)2025-12-31$49.38M+34.9%

Compare YDES, SERA, ACON, BGLC side by side · Screen every company in Services-Medical Laboratories ↗